Outcomes Of Preloaded Versus Surgeon Prepared Tri-Folded Endothelium-In Descemet Membrane Endothelial Keratoplasty
Published 2023 - 41st Congress of the ESCRS
Reference: PP24.02 | Type: Free paper | DOI: 10.82333/tbpn-bq15
Authors: Linda Marie Louise Busin* 1 , Rossella Spena 2 , Angeli Christy Yu 2 , Marco Pellegrini 2 , Cristina Bovone 2 , Massimo Busin 2
1Ophthalmology,Ospedali Privati Forlì, “Villa Igea”,Forlì,Italy;Biomedical and Clinical Science ,Eye Clinic ''Luigi Sacco Hospital'',Milan,Italy, 2Ophthalmology,Ospedali Privati Forlì, “Villa Igea”,Forlì,Italy;Translational Medicine,University of Ferrara,Ferrara,Italy
Purpose
To compare the clinical outcomes of preloaded versus surgeon prepared tri-folded endothelium-in Descemet membrane endothelial keratoplasty (DMEK)
Setting
Ospedali Privati Forlì, "Villa Igea", Forlì, Italy
Methods
In this comparative, retrospective interventional case series, medical records of 69 cases of preloaded tri-folded endothelium-in DMEK from November 2016 to March 2018 were reviewed. The outcomes were compared with an age-matched control group (n=69) of surgeon prepared tri-folded endothelium-in DMEK surgeries. Main outcome measures were best spectacle-corrected visual acuity (BSCVA), endothelial cell loss and postoperative complication rates.
Results
Preoperative logMAR BSCVA was 0.97±0.63 in the preloaded DMEK group and 0.94±0.71 in the surgeon prepared DMEK group. At 6 months, both groups showed significant improvement in visual acuity (p<0.001). BSCVA did not differ significantly between both groups at all time points examined. In all eyes, DMEK surgery was uneventful. However, compared to surgeon prepared DMEK, mean endothelial cell loss was significantly higher in the preloaded DMEK group (p<0.001) Rebubbling rates did not differ significantly between the two groups.
Conclusions
Although visual outcomes and rebubbling rates of preloaded tri-folded endothelium-in DMEK are comparable to those of surgeon-prepared DMEK, use of preloaded grafts is associated with a higher rate of endothelial cell loss.